News Pfizer axes Alzheimer's and Parkinson's research Big pharma will continue developing tanezumab painkiller with Lilly
News Acorda axes Parkinson's drug after trial deaths Biotech not confident white blood cell counts could ensure patient safety.
Partner Content Partner Content 2018 Agenda Released: World CNS Summit Targeting Neurodegenerative Diseases
News Allergan negotiates option to buy neurology biotech Allergan to co-develop Parkinson's drug with Lysosomal Therapeutics
News Verily’s ‘smart spoon’ combats Parkinson’s tremors Device allows those with neurodegenerative disorders to eat without spilling their food.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
